psychedelics
Here you will find coverage of psychedelic drugs, which are drawing enormous interest as possible treatments for mental illnesses such as depression, post-traumatic stress disorder (PTSD), and anxiety. Long-stigmatized drugs such as psilocybin and MDMA are moving through clinical trials, and the anesthetic ketamine has gained popularity as a treatment for serious depression in combination with psychotherapy.
Latest
STAT Plus: A Harvard-affiliated hospital is testing magic mushrooms on dying patients
Mind-altering ketamine becomes latest pain treatment, despite little research or regulation
STAT Plus: New study adds to evidence on psychedelic as effective treatment for PTSD
I cured my ARFID with psilocybin. I shouldn’t have needed to self-treat it
STAT Plus: One dose of psilocybin may have lasting effects on major depression, study finds
STAT Plus: How the political right came to back psychedelics to treat trauma
As psychedelics near approval, there’s no consensus on how they work
All Coverage
advertisement
